{
    "organizations": [],
    "uuid": "47857bb35806eff3e22fdcdc275b567295e47b51",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-albireo-enrolls-first-patient-in-p/brief-albireo-enrolls-first-patient-in-phase-3-pfic-trial-of-a4250-idUSASC0A2LP",
    "ord_in_thread": 0,
    "title": "BRIEF-Albireo Enrolls First Patient In Phase 3 PFIC Trial Of A4250",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - Albireo Pharma Inc:\n* ALBIREO ENROLLS FIRST PATIENT IN PHASE 3 PFIC TRIAL OF A4250 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-16T20:36:00.000+03:00",
    "crawled": "2018-05-17T14:27:02.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "albireo",
        "pharma",
        "inc",
        "albireo",
        "enrolls",
        "first",
        "patient",
        "phase",
        "pfic",
        "trial",
        "a4250",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}